Rights Issue6 Aug 2026, 02:47 pm
Sarda Proteins Approves Rights Issue Up to ₹100 Crore
AI Summary
Sarda Proteins Limited's Board of Directors has approved a rights issue of equity shares, aiming to raise up to ₹10,000 lakhs (₹100 crore). The board also approved the Draft Letter of Offer (DLOF) for the issue and constituted a Rights Issue Committee. Additionally, the company noted the resignation of non-executive director Mr. Gunvantray Jayantilal Zaladi, effective August 5, 2026, due to personal reasons and pre-occupations. The record date for the rights issue will be intimated separately.
Key Highlights
- Board approved rights issue to raise up to ₹100 crore.
- Draft Letter of Offer approved for SEBI and stock exchanges.
- A Rights Issue Committee has been formed to oversee the process.
- Non-executive director Mr. Gunvantray Jayantilal Zaladi resigned.
- Record date for the rights issue to be announced later.
Price Impact
More from SRDAPRT